Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2023 > Vol 4, №4 (2023) > Chronic prostatitis and male infertility

Chronic prostatitis and male infertility

Lev E. Belyi

For citation:


  • Abstract
  • About the Author
  • References

Abstract

One of the factors that can lead to the development of male infertility is an infection of the genitourinary tract. An infectious and inflammatory process affecting the male reproductive system can cause various disorders of reproductive function: a disorder of gametogenesis in the testicles, disorders of sperm maturation in the epididymis, and passage of sperm along the vas deferens, as well as a decrease in some parameters of the ejaculate due to inflammatory dysfunction of the male accessory glands. Prostatitis is one of the most common urological diseases in young men. Prostatitis accounts for 25% of all requests for medical help to a urologist, and from 2 to 10% of men suffer from prostatitis symptoms. The disease is polyethological, and infection, immunological reactions, urethro-prostatic reflux of urine, psychoemotional stress are mentioned as the main causes of its development today. It is obvious that a pathological process with complex pathogenetic mechanisms affecting the prostate gland can have a negative impact on male fertility. This review examines the key mechanisms of the development of male infertility in chronic prostatitis. 
Key words: male infertility, spermogram, chronic prostatitis, leukocytospermia, male factor, male accessory gland infection.

About the Author

Lev E. Belyi 1

1 Ulyanovsk State University, Ulyanovsk, Russia

References

1. Cannarella R, Calogero AE. Male infertility: from etiology to management. Minerva Endocrinol (Torino) 2022; 47 (1): 1‒3. 
2. Levine H, Jørgensen N, Martino-Andrade A et al. Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update 2017; 23: 646–59. 
3. Винник Ю.Ю., Борисов В.В. Мужское бессплодие: современное состояние проблемы. Клиническая лекция. Consilium Medicum. 2017; 19 (7): 65–9. [Vinnik Yu.Yu., Borisov V.V. Muzhskoe bessplodie: sovremennoe sostoyanie problemy. Klinicheskaya lekciya. Consilium Medicum. 2017; 19 (7): 65–9. (in Russian).] 
4. World Health Organization. WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. 2000, Cambridge University Press: Cambridge. 
5. Коршунов М.Н. Инфекции и мужская фертильность. Бесплодный брак. Методическое пособие для акушеров-гинекологов, репродуктологов, урологов и врачей смежных специальностей. 2021. https://fertility-today.ru/metodicheskoe-posobie/Metod_A4_ Resolution.pdf [Korshunov M.N. Infekcii i muzhskaya fertil'nost'. Besplodnyj brak. Metodicheskoe posobie dlya akusherov-ginekologov, reproduktologov, urologov i vrachej smezhnyh special'nostej. 2021. https://fertility-today.ru/metodicheskoe-posobie/Metod_A4_Resolution.pdf (in Russian).] 
6. Khan FU, Ihsan AU, Khan HU et al. Comprehensive overview of prostatitis. Biomed Pharmacother. 2017; 94: 1064‒76. 
7. Habermacher GM, Chason JT, Schaeffer AJ. Prostatitis/chronic pelvic pain syndrome. Annu Rev Med 2006; 57: 195–206.
8. Ejike CE, Ezeanyika LU. Prevalence of chronic prostatitis symptoms in a randomly surveyed adult population of urban-communitydwelling Nigerian males. Int J Urol 2008; 15 (4): 340–3. 
9. Krieger JN, Nyberg LJr, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA 1999; 282 (3): 236–7. 
10. Hu XY, Xu YM, Qiao Y et al. Reduced semen quality in chronic prostatitis patients that induce the release of apoptotic protein Omi/HtrA2 from spermatozoa. Prostate Cancer Prostatic Dis 2007; 10 (1): 104–8. 
11. Кузнецкий Ю.Я. Критический взгляд на проблему диагностики хронического простатита. Андрология и генитальная хирургия. 2005; 6 (2): 6–11. [Kuzneckij Yu.Ya. Kriticheskij vzglyad na problemu diagnostiki hronicheskogo prostatita. Andrologiya i genital'naya hirurgiya. 2005; 6 (2): 6–11 (in Russian).] 
12. Calogero AE, Duca Y, Condorelli RA et al. Male accessory gland inflammation, infertility, and sexual dysfunctions: a practical approach to diagnosis and therapy. Andrology 2017; 5 (6): 1064–72. 
13. Litwin M, McNaughton-Collins M, Fowler FJ. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol 1999; 162: 369–75. 
14. La Vignera S, Condorelli R, Vicari E et al. High frequency of sexual dysfunction in patients with male accessory gland infections. Andrologia 2012; 44 (Suppl. 1): 438–46. 
15. La Vignera S, Vicari E, Condorelli RA et al. Male accessory gland infection and sperm parameters (review). Int J Androl 2011; 34: 330–47. 
16. Rowe PJ et al. WHO manual for the standardized investigation and diagnosis of the infertile couple. Press Syndicate of the University of Cambridge, Cambridge, 1993. 
17. Henkel R, Offor U, Fisher D. The role of infections and leukocytes in male infertility. Andrologia 2021; 53: e13743. 
18. Johanisson E, Campana A, Luthi R et al. Evaluation of ‘round cells’ in semen analysis: a comparative study. Hum Reprod Update 2000; 6: 404–12. 
19. Wolff H. The biologic significance of white blood cells in semen. Fertil Steril 1995; 63: 1143–57. 
20. Bachir BG, Jarvi K. Infectious, inflammatory, and immunologic conditions resulting in male infertility. Urol Clin North Am 2014; 41: 67–81. 
21. Shy KK, Stenchever MA, Muller CH. Sperm penetration assay and subsequent pregnancy: a prospective study of 74 infertile men. Obstet Gynecol 1988; 71: 685–90. 
22. Domes T, Lo KC, Grober ED et al. The incidence and effect of bacteriospermia and elevated seminal leukocytes on semen parameters. Fertil Steril 2012; 97: 1050–5. 
23. Gambera L, Serafini F, Morgante G et al. Sperm quality and pregnancy rate after COX-2 inhibitor therapy of infertile males with abacterial leukocytospermia. Hum Reprod 2007; 22: 1047–51. 
24. Eggert-Kruse W, Boit R, Rohr G et al. Relationship of seminal plasma interleukin (IL) -8 and IL-6 with semen quality. Hum Reprod 2001; 16 (3): 517‒28. 
25. Martínez-Prado E, Camejo Bermúdez MI. Expression of IL-6, IL-8, TNF-alpha, IL-10, HSP-60, anti-HSP-60 antibodies, and anti-sperm antibodies, in semen of men with leukocytes and/or bacteria. Am J Reprod Immunol 2010; 63 (3): 233–43. 
26. Ignjatović I. Fiziološki mehanizmi penilne erekcije i detumescencije. In: Bašić D, Hadži-Djokić J, Austoni E, editors. Muška seksualna funkcija i poremećaji. Niš: Medicinski fakultet Univerziteta u Nišu, 2012; p. 23–8. 
27. Божедомов В.А., Семенов А.В., Конышев А.В. Репродуктивная функция мужчин при хроническом простатите: клинико-анамнестические и микробиологические аспекты. Урология 2015; 1: 70–8. [Bozhedomov V.A., Semenov A.V., Konyshev A.V. Reproduktivnaya funkciya muzhchin pri hronicheskom prostatite: kliniko-anamnesticheskie i mikrobiologicheskie aspekty. Urologiya 2015; 1: 70–8 (in Russian).] 
28. Saleh RA, Agarwal A, Kandirali E et al. Leukocytospermia is associated with increased reactive oxygen species production by human spermatozoa. Fertil Steril 2002; 78 (6): 1215–24. 
29. Plante M, de Lamirande E, Gagnon C. Reactive oxygen species released by activated neutrophils, but not by deficient spermatozoa, are sufficient to affect normal sperm motility. Fertil Steril 1994; 62 (2): 387–93. 
30. Aitken RJ, Buckingham DW, Brindle J et al. Analysis of sperm movement in relation to the oxidative stress created by leukocytes in washed sperm preparations and seminal plasma. Hum Reprod 1995; 10: 2061–71. 
31. Negre-Salvayre A, Coatrieux C, Ingueneau C et al. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 2008; 153: 6–20. 
32. Elia J, Delfino M, Imbrogno N, et al. Human semen hyperviscosity: prevalence, pathogenesis and therapeutic aspects. Asian J Androl 2009; 11: 609–15. 
33. Flint M, du Plessis SS, Menkveld R. Revisiting the assessment of semen viscosity and its relationship to leucocytospermia. Andrologia 2014; 46: 837–41. 
34. Du Plessis SS, Gokul S, Agarwal A. Semen hyperviscosity: causes, consequences, and cures. Front Biosci (Elite Ed) 2013; 5 (1): 224–31. 
35. Munuce MJ, Bregni C, Carizza C et al. Mendeluk: Semen culture, leukocytospermia, and the presence of sperm antibodies in seminal hyperviscosity. Arch Androl 1999; 42: 21–8. 
36. Gopalkrishnan K, Hinduja IN, Latha P et al. Mehta: Role of microbial study in selection of subjects for in vitro fertilization & embryo transfer (IVF-ET). Indian J Med Res 1988; 88: 141–5 
37. Gonzales GF, Kortebani G, Mazzolli AB. Hyperviscosity and hypofunction of the seminal vesicles. Arch Androl 1993; 30 (1): 63–8. 
38. Emami N, Scorilas A, Soosaipillai A et al. Association between kallikrein-related peptidases (KLKs) and macroscopic indicators of semen analysis: their relation to sperm motility. Biol Chem 2009; 390 (9): 921–9.


For citation:Belyi L.E. Chronic prostatitis and male infertility. Clinical review for general practice. 2023; 4 (4): 89–93. DOI: 10.47407/kr2023.4.4.00261


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru